|
|
| |
| |
Your access to vital information on breast cancer is now easier, with comprehensive coverage of this topic at your fingertips. ASCO has gathered and synthesized data on breast cancer from a multitude of key sources, including the Journal of Clinical Oncology and other ASCO publications, the Virtual Meeting, and more. Experience the ease of finding in-depth information on breast cancer topics, and visit often to remain current with timely updates.
|
|
| |
|
JCO Highlighted Breast Cancer Articles
|
Last Updated: May 29, 2009
|
 |
|
Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
(JCO, May 2009)
|
|
|
Oxidative Stress, Obesity, and Breast Cancer Risk: Results From the Shanghai Women's Health Study
(JCO, May 2009)
|
|
|
Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer
(JCO, May 2009)
|
|
|
Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
(JCO, May 2009)
|
|
|
Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer
(JCO, May 2009)
|
|
|
|
|
Medline Latest Breast Cancer Articles
|
Last Updated: June 28, 2009
|
|
|
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
(J Clin Oncol, 2009 Apr)
|
|
|
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
(J Clin Oncol, 2009 Apr)
|
|
|
Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study.
(Lancet Oncol, 2009 May)
|
|
|
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study.
(Lancet Oncol, 2009 Apr)
|
|
|
Xoft Axxent electronic brachytherapy: a new device for delivering brachytherapy to the breast.
(Nat Clin Pract Oncol, 2009 Mar)
|
|
|
|
|
Virtual Meeting
|
|
|
|
|
|
|
|
|
|
New highlights on the biological, clinical, and prognostic implications of p53 transcriptional status in breast cancers
(General Session IV: Triple Negative Breast Cancer: What's Positive? (General Session))
|
|
|
Disease associations of fgfr2, tnrc9, and map3k1 polymorphisms in breast cancer
(Oral Abstract Presentation Session A (Oral Presentation))
|
|
|
Two-year evaluation of clinical use of an intraoperative RT-PCR assay for the detection of metastases in sentinel lymph nodes of patients with breast cancer at the Institut Jules Bordet
(General Session V: Selected Controversies in Pathology (General Session))
|
|
|
|
|
Abstracts
|
|
|
Search the 2008 breast cancer abstracts as well as abstracts back through the 2000 Annual Meeting
|
|
|
|
Educational Book
|
|
|
Find breast cancer manuscripts grouped into areas of interest, or search the 2002-2009 Educational Books archive.
|
|
|
|
Cancer.Net
|
|
|
Find information and resources to support your patients living with breast cancer
|
|
|
|
|
|
|
|
 |
|
ASCO Annual Meeting 2009
Orlando Convention Center
May 29 - June 2
|
|
This online resource is supported by:
|
|
|
|
|
|
